
As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.
Kimberly J. Van Zee, MS, MD, FACS, discusses difficult decisions women with a Ductal carcinoma in situ (DCIS) diagnosis face.
Kimberly J. Van Zee, MS, MD, FACS, discusses tough decisions women with a Ductal carcinoma in situ (DCIS) diagnosis face. While DCIS is considered to be a better diagnosis than invasive breast cancer, it also can be a confusing one, and patients facing DCIS often find it very difficult to choose among different treatment options.






